The clinical risk and post-COVID-19 sequelae in patients with myasthenia gravis: a retrospective observational study
Compared to normal patients, MG patients are prone to developing severe COVID-19 infection, which is associated with the daily corticosteroid dose and the frequency of myasthenia crises pre-COVID-19. Additionally, they are prone to experiencing post-COVID-19 sequelae, including insomnia, myalgia, dizziness, cough, expectoration, and sore throat, at 12 months after recovery.
Authors
- Yufei Deng (ORCID: https://orcid.org/0009-0009-6953-6771)
- Chaoyue Zhang (ORCID: https://orcid.org/0000-0002-9816-9204)
- Qilong Jiang (ORCID: https://orcid.org/0000-0001-9387-1259)
- Yu‐Tao Xiang (ORCID: https://orcid.org/0000-0002-2906-0029)
- Jiaxin Liu (ORCID: https://orcid.org/0000-0002-7048-1992)
- Haocheng Luo
- Hongjin Li (ORCID: https://orcid.org/0000-0002-5466-1192)
- Linqi Huang
- Xiaojun Yang (ORCID: https://orcid.org/0000-0001-9833-6415)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-04-02
- DOI
- https://doi.org/10.3389/fneur.2025.1513649
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00